Streetbeat News

Regulatory

ICU

SeaStar Medical has reached a significant milestone in its adult acute kidney injury trial by enrolling 51 subjects, surpassing the halfway mark. The accelerated recruitment is bringing the trial closer to its 100-subject interim analysis target, which will evaluate the 90-day primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 12:32 pm

ARQT

Arcutis Biotherapeutics has received Health Canada approval for ZORYVE Foam 0.3% to treat seborrheic dermatitis in patients aged 9 and older. This marks the first new mechanism topical treatment for the condition in Canada in over 20 years.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 12:22 pm

ALNY

Alnylam Canada has signed a Letter of Intent with the pan-Canadian Pharmaceutical Alliance for the public reimbursement of AMVUTTRA, a treatment for hereditary transthyretin-mediated amyloidosis in adults. This follows positive recommendations from Canadian health agencies.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 12:17 pm

EIS

ISRA

Hamas official Al-Hayya states the group will continue its efforts until Palestinian ambitions are met. He claims the death of Sinwar will strengthen Hamas and warns that Israeli hostages will not be released until aggression on Gaza ceases.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 12:11 pm

QQQ

SPY

Kevin Hassett, a potential Federal Reserve nominee by Donald Trump, defends the recent interest rate cut despite Trump's criticism. The rate cut has led to a surge in the S&P 500 and gold prices, with small-cap stocks also rallying.

Portfolio Pulse from Benzinga Neuro

October 18, 2024 | 11:47 am

AGR

Avangrid's subsidiary has secured a $31.8 million federal grant from the U.S. Department of Energy's GRIP program, funded by the Bipartisan Infrastructure Law, to deploy advanced grid technology.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 11:33 am

USM

VZ

United States Cellular (UScellular) has entered into an agreement with Verizon to sell a portion of its spectrum licenses for $1 billion. This transaction is part of UScellular's strategy to monetize its spectrum assets. The deal is subject to regulatory approvals.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 11:32 am

CI

CVS

UNH

CVS Health has appointed David Joyner as the new CEO amid financial struggles, with third-quarter earnings expected to miss projections. The company is backing away from its annual forecast and facing FTC complaints. CVS is also considering restructuring its retail and insurance businesses.

Portfolio Pulse from Vandana Singh

October 18, 2024 | 11:14 am

THS

Treehouse Foods has announced a voluntary recall of certain waffle products due to potential Listeria contamination. The affected products were distributed in the US and Canada.

Portfolio Pulse from Nabaparna Bhattacharya

October 18, 2024 | 10:57 am

ISRG

NFLX

Intuitive Surgical shares rose 6.9% in pre-market trading due to better-than-expected Q3 results and regulatory clearance in South Korea. Netflix also gained 5.8% after strong Q3 results. Several other stocks experienced significant pre-market movements.

Portfolio Pulse from Avi Kapoor

October 18, 2024 | 10:52 am